Skip to content

BIOSPECIFICS TECHNOLOGIES CORP: 10-Q filed 2018-11-09

What BIOSPECIFICS TECHNOLOGIES CORP reported in its quarterly report filed 2018-11-09 (fiscal Q3 2018): 35 published measures, 121 facts as tagged in accession 0001140361-18-042823.

This filing

Form
10-Q (quarterly report)
Filed
2018-11-09
Fiscal period
fiscal Q3 2018
Accession
0001140361-18-042823 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIOSPECIFICS TECHNOLOGIES CORP filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-09-3093,552,934USD
At 2018-06-3090,084,680USD
At 2017-12-3174,996,394USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-09-3091,742,421USD
At 2018-06-3087,484,072USD
At 2017-12-3167,516,838USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-09-3013,381,013USD
At 2017-12-317,333,810USD
At 2017-09-306,422,358USD
At 2016-12-314,763,364USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-07-01 to 2018-09-305,043,050USD92
2018-01-01 to 2018-09-3013,869,585USD273
2018-04-01 to 2018-06-304,847,931USD91
2018-01-01 to 2018-06-308,826,535USD181
2017-07-01 to 2017-09-302,714,832USD92
2017-01-01 to 2017-09-308,683,675USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-01-01 to 2018-09-3012,274,099USD273
2017-01-01 to 2017-09-309,371,866USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2018-07-01 to 2018-09-308,168,081USD92
2018-01-01 to 2018-09-3023,108,264USD273
2018-04-01 to 2018-06-307,850,774USD91
2018-01-01 to 2018-06-3014,940,183USD181
2017-07-01 to 2017-09-306,516,108USD92
2017-01-01 to 2017-09-3020,742,243USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-01-01 to 2018-09-3011,780USD273
2017-01-01 to 2017-09-30-358,249USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-6,238,676USD273
2017-01-01 to 2017-09-30-7,354,623USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-09-3065,993,035USD
At 2018-06-3060,949,985USD
At 2017-12-3141,939,115USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2018-07-01 to 2018-09-307,281,388shares92
2018-01-01 to 2018-09-307,230,106shares273
2017-07-01 to 2017-09-307,164,934shares92
2017-01-01 to 2017-09-307,166,470shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2018-07-01 to 2018-09-307,356,885shares92
2018-01-01 to 2018-09-307,327,029shares273
2017-07-01 to 2017-09-307,314,609shares92
2017-01-01 to 2017-09-307,325,602shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2018-07-01 to 2018-09-300.69USD/shares92
2018-01-01 to 2018-09-301.92USD/shares273
2018-04-01 to 2018-06-300.67USD/shares91
2018-01-01 to 2018-06-301.23USD/shares181
2017-07-01 to 2017-09-300.38USD/shares92
2017-01-01 to 2017-09-301.21USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2018-07-01 to 2018-09-300.69USD/shares92
2018-01-01 to 2018-09-301.89USD/shares273
2018-04-01 to 2018-06-300.66USD/shares91
2018-01-01 to 2018-06-301.21USD/shares181
2017-07-01 to 2017-09-300.37USD/shares92
2017-01-01 to 2017-09-301.19USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2018-07-01 to 2018-09-301,089,966USD92
2018-01-01 to 2018-09-303,271,366USD273
2018-04-01 to 2018-06-301,102,826USD91
2018-01-01 to 2018-06-302,181,400USD181
2017-07-01 to 2017-09-301,477,057USD92
2017-01-01 to 2017-09-304,669,569USD273

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-01-01 to 2018-09-30159,883USD273
2017-01-01 to 2017-09-30100,428USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-07-01 to 2018-09-305,773,379USD92
2018-01-01 to 2018-09-3016,192,954USD273
2018-04-01 to 2018-06-305,595,026USD91
2018-01-01 to 2018-06-3010,419,575USD181
2017-07-01 to 2017-09-303,983,760USD92
2017-01-01 to 2017-09-3012,876,383USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-09-3087,669,194USD
At 2018-06-3082,156,626USD
At 2017-12-3166,380,515USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-09-301,810,513USD
At 2018-06-302,600,608USD
At 2017-12-312,138,848USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-09-3014,455,354USD
At 2018-06-3013,648,258USD
At 2017-12-314,655,105USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2018-01-01 to 2018-09-302,559,050USD273
2017-01-01 to 2017-09-30616,499USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2018-07-01 to 2018-09-30162,625USD92
2018-01-01 to 2018-09-30569,648USD273
2017-07-01 to 2017-09-30356,847USD92
2017-01-01 to 2017-09-30949,359USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-09-307,283,528shares
At 2017-12-317,189,233shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-09-3036,198,898USD
At 2017-12-3133,468,323USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2018-09-30439,892USD
At 2017-12-31397,993USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2018-09-30801,956USD
At 2017-12-31623,503USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2018-09-300USD
At 2017-12-311,057,979USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2018-09-30300,000USD
At 2017-12-311,700,000USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2018-07-01 to 2018-09-306,133,016USD92
2018-01-01 to 2018-09-3017,140,951USD273
2018-04-01 to 2018-06-305,950,757USD91
2018-01-01 to 2018-06-3011,007,935USD181
2017-07-01 to 2017-09-304,191,889USD92
2017-01-01 to 2017-09-3013,353,244USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-07-01 to 2018-09-302,232,077USD92
2018-01-01 to 2018-09-306,345,662USD273
2018-04-01 to 2018-06-302,043,952USD91
2018-01-01 to 2018-06-304,113,585USD181
2017-07-01 to 2017-09-302,175,501USD92
2017-01-01 to 2017-09-306,916,501USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2018-01-01 to 2018-09-301,984,577USD273
2017-01-01 to 2017-09-301,632,823USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2018-07-01 to 2018-09-300USD92
2018-01-01 to 2018-09-3096,663USD273
2017-07-01 to 2017-09-3014,667USD92
2017-01-01 to 2017-09-3040,651USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2018-07-01 to 2018-09-30359,637USD92
2018-01-01 to 2018-09-30947,997USD273
2017-07-01 to 2017-09-30208,129USD92
2017-01-01 to 2017-09-30476,861USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2018-01-01 to 2018-09-300USD273
2017-01-01 to 2017-09-300USD273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2018-01-01 to 2018-09-303,917,572USD273
2017-01-01 to 2017-09-304,410,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-09-302,245,522USD273
2018-01-01 to 2018-06-301,438,426USD181
2017-01-01 to 2017-09-30871,093USD273

Inspect the source

Entity
BIOSPECIFICS TECHNOLOGIES CORP / CIK 0000875622
Captured
SEC response SHA-256
b1d443fa8a2de5e07d7cbcf40e33944d546011c718a394f04bbb863281862def

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000875622.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))